Genome Valley
Life Sciences
CountryIndia India
State Telangana
CityHyderabad
DistrictMedchal-Malkajgiri district
Established22 November 1999 (1999-11-22)
Founded byGovernment of Andhra Pradesh (1956–2014)
Area
 • Total8.1 km2 (3.1 sq mi)
Websitelifesciences.telangana.gov.in/life-sciences-grid/clusters/genome-valley/
genomevalley.co
www.mnpark.in
www.ikpknowledgepark.com
www.innopolis-gv.com

Genome Valley is an Indian high-technology business district spread across 2,000-acre (8.1 km2)/(3.1 sq mi) in Hyderabad, India.[1][2] It is located across the suburbs, Turakapally, Shamirpet, Medchal, Uppal, Patancheru, Jeedimetla, Gachibowli and Keesara. The Genome Valley has developed as a cluster for Biomedical research, training and manufacturing.[3][4][5] Genome Valley is now into its Phase III, which is about 11 km from the Phase I and II with the total area approximately 2,000-acre (8.1 km2).[6]

History

Clockwise from upper left:

Genome Valley was an initiative of N. Chandrababu Naidu, the then Chief Minister of Andhra Pradesh and was commissioned in 1999 as S. P. Biotech Park in a public-private partnership with Bharat Biotech International, and its founder Krishna Ella, alongside private infrastructure companies such as Shapoorji Pallonji Group and ICICI Bank.[7]

Alexandria Knowledge Park SEZ

In 2009, U.S.-based infrastructure giant Alexandria Real Estate Equities has announced its plans to invest in the bio-cluster, which led to the Alexandria Knowledge Park SEZ.[8] The bio-cluster at Shamirpet holds Certification mark by the United States Patent and Trademark Office and the European Union.[9]

IKP Knowledge Park

The IKP Knowledge Park is spread over 200 acres in Turakapally, is an initiative of ICICI Bank with five "innovation corridors" - a first of its kind knowledge-nurturing centre for Indian companies and a knowledge gateway for multinational companies".[10] The first phase of Innovation Corridor I, comprising 10 laboratories, around 3,000 ft² (300 m²) each, is operational and fully occupied. The second phase of Innovation Corridor I, comprising 16 laboratory modules of 1,700 ft² (170 m²) each, is ready for operation.

MN Park

Clockwise from upper left:

In 2016, Mission Neutral Park has acquired specialized R&D assets in Genome Valley from U.S.-based Alexandria REIT and rechristened it as MN Park. It is a collaborative life sciences ecosystem in Genome Valley, Hyderabad consisting of Grade A R&D facilities.

MN Park is spread over 400 acres including build-up facilities of around 600,000 sq.ft. provided to global tenants like Novartis, GlaxoSmithKline, Mylan and Ashland Inc. MN’s focus area: Preleased industrial assets and specialized office spaces to sectors including specialized warehousing, logistics, food processing, light manufacturing, pharmaceutical R&D, biotechnology, etc.

Big Pharma and Consulting

Clinical and Healthcare IT

Manufacturing

R & D

Small Biotechs

See also

References

  1. ↑ "Pharma majors queue up for space at Hyderabad's Genome Valley". The Times of India. 4 August 2020.
  2. ↑ Special Correspondent (22 November 2011). "Today's Paper / NATIONAL : BioAsia-2012 to focus on vaccines, IPR, CROs and investments". The Hindu. Retrieved 21 August 2012.
  3. ↑ "BioSpectrumIndia - the business of biotech - Moving Towards Consolidation". Biospectrumindia.ciol.com. Archived from the original on 5 November 2008. Retrieved 21 August 2012.
  4. ↑ Our Bureau (12 February 2012). "Business Line : Industry & Economy / Economy : AP Govt making policies more industry-friendly, says CM". Thehindubusinessline.com. Retrieved 21 August 2012.
  5. ↑ Our Bureau. "Business Line : Industry & Economy News : Tag from US lab may help drug-makers find markets". Thehindubusinessline.com. Retrieved 21 August 2012.
  6. ↑ "Valley of Growth". The Hindu. 4 November 2022.
  7. ↑ rediff. "Genome valley history". Retrieved 21 August 2012.
  8. ↑ The Hindu (21 May 2009). "Alexandria to invest 1000 cr in genome valley". The Hindu. Retrieved 21 August 2012.
  9. ↑ Hyderabad's Genome Valley gets US certification, Indo Asian News Service Friday, 6 July 2007 | publisher=india-forums.com
  10. ↑ "iciciknowledgepark.com". Archived from the original on 24 September 2015. Retrieved 20 September 2015.
  11. ↑ "Novartis India Limited, Amit Kumar, Dr Anuradha Sinha". Businesswireindia.com. 13 August 2009. Retrieved 21 August 2012.
  12. ↑ Bureau, BL Hyderabad (1 February 2023). "Sandoz to set up global capability centre in Hyderabad". BusinessLine.
  13. ↑ "Hyderabad: Roche Pharma sets up its second data analytics centre in India". 18 October 2022.
  14. ↑ "Bristol-Myers Squibb to invest $100 million in Hyderabad to set up innovation centre". 23 February 2023.
  15. ↑ IANS (18 September 2014). "P&G, Cogent open Telangana plants, Johnson & Johnson begins work". business-standard.com.
  16. ↑ Bayer Archived 2013-11-04 at the Wayback Machine
  17. ↑ Our Bureau. "Bayer launches multi-crop breeding station in Hyderabad". The Hindu Business Line.
  18. ↑ "US Pharmacopeia to set up lab in Hyderabad". Archived from the original on 18 June 2006. Retrieved 19 February 2006.
  19. ↑ "'Lonza is investing Rs.405 cr in India'". biospectrumindia.com. Archived from the original on 2 October 2013. Retrieved 28 June 2013.
  20. ↑ "GSK looking to invest more in Hyderabad". The Hindu. 19 May 2022 – via www.thehindu.com.
  21. ↑ Udgirkar, Trushna. "Biocon to spend Rs 200 cr on R&D, manufacturing". mydigitalfc.com. Archived from the original on 22 March 2012. Retrieved 21 August 2012.
  22. ↑ Our Bureau. "Business Line : Industry & Economy / Agri-biz : Monsanto opens Rs 28 cr seed conditioning facility at Shamirpet". Thehindubusinessline.com. Retrieved 21 August 2012.
  23. ↑ "Merck completes talks with IKP on R&D unit". The Hindu. Chennai, India. 18 February 2007.
  24. ↑ "Covidien's New R&D Centre in Hyderabad - Express Healthcare". Expresshealthcare.in. Retrieved 21 August 2012.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.